MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cam4.4476

Медицинская библиотека · Cancer medicine · 2021

The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.

Kim Jwa Hoon, Seo Seyoung, Kim Jee Hyun, Koh Su-Jin, Ahn Yongchel, Jung Kyung Hae, Ahn Jin-Hee, Kim Sung-Bae, Kim Tae Won, Hong Yong Sang, Kim Sun Young, Kim Jeong Eun, Kim Sang-We, Lee Dae Ho, Lee Jae Cheol, Choi Chang-Min, Yoon Shinkyo, Jeong Jae Ho, Kim Hwa Jung, Suh Koung Jin, Kim Se Hyun, Kim Yu Jung, Min Young Joo, Baek Jin Ho, Park Sook Ryun

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

This study was conducted to compare the reported adverse event (AE) profiles and unexpected use of medical services during chemotherapy between before and after the healthcare reimbursement of AE evaluation in patients with cancer.

PATIENTS AND

METHODS

Using the electronic medical record database system, extracted patients with breast, lung, gastric, and colorectal cancers receiving neoadjuvant or adjuvant chemotherapy between September 2013 and December 2016 at four centers in Korea were matched using the 1:1 greedy method: pre-reimbursement group (n = 1084) and post-reimbursement group (n = 1084). Unexpected outpatient department (OPD), emergency room (ER) visit, hospitalization rates, and chemotherapy completion rates were compared between the groups.

RESULTS

The baseline characteristics were well-balanced between the groups. By chemotherapy cycle, hospitalization (1.8% vs. 2.3%; p = 0.039), and ER visit rates (3.3% vs. 3.9%; p = 0.064) were lower in the post-reimbursement group than that in the pre-reimbursement group. In particular, since cycle 2, ER visit and hospitalization rates were significantly lower in the post-reimbursement group than those in the pre-reimbursement group (2.6% vs. 3.3%; p = 0.020 and 1.4% vs. 2.0%; p = 0.007, respectively), although no significant differences were observed during cycle 1. The OPD visit rates were similar between both groups, regardless of cycles. The post-reimbursement group had a higher proportion of patients who completed chemotherapy as planned than the pre-reimbursement group (93.5% vs. 90.1%; p = 0.006). Post-reimbursement group had more AEs reported, including alopecia, fatigue, diarrhea, anorexia, and peripheral neuropathy, during cycle 1 than the pre-reimbursement group, which significantly decreased after cycle 2.

CONCLUSION

The introduction of healthcare reimbursement for AE evaluation may help physicians capture and appropriately manage AEs, consequently, decreasing hospital utilization and increasing chemotherapy completion rates.

Для цитирования: Kim Jwa Hoon, Seo Seyoung, Kim Jee Hyun, Koh Su-Jin, Ahn Yongchel, Jung Kyung Hae, Ahn Jin-Hee, Kim Sung-Bae, Kim Tae Won, Hong Yong Sang, Kim Sun Young, Kim Jeong Eun, Kim Sang-We, Lee Dae Ho, Lee Jae Cheol, Choi Chang-Min, Yoon Shinkyo, Jeong Jae Ho, Kim Hwa Jung, Suh Koung Jin, Kim Se Hyun, Kim Yu Jung, Min Young Joo, Baek Jin Ho, Park Sook Ryun. The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.. Cancer medicine. 2021. DOI: 10.1002/cam4.4476.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.